Article
NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomas
2023-12-14
Abstract excerpt
Immune checkpoint blockade (ICB) has become a standard of care in the treatment of metastatic melanoma (MM). Although ICB is particularly successful in some MM patients, more than half do not obtain a durable benefit. Biomarkers that predict response are urgently needed and overcoming intrinsic resistance is key to improving the success of ICB therapy. Using single cell RNA sequencing, we characterized the immune...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bbbaef7-0990-5a63-912d-4c356796be0a
- DOI
- 10.1101/2023.12.14.571631
